D
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Price:
11.56
USD
-2.69%
Market Cap:
$1.2B
Balance Sheet
Balance Sheet Decomposition
Day One Biopharmaceuticals Inc
Day One Biopharmaceuticals Inc
Balance Sheet Decomposition is not available for
Day One Biopharmaceuticals Inc
Day One Biopharmaceuticals Inc
Balance Sheet
Day One Biopharmaceuticals Inc
Day One Biopharmaceuticals Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
27
|
44
|
284
|
85
|
231
|
125
|
|
| Cash |
27
|
44
|
284
|
85
|
231
|
125
|
|
| Short-Term Investments |
0
|
0
|
0
|
257
|
136
|
407
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
14
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
14
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
3
|
|
| Other Current Assets |
0
|
1
|
5
|
6
|
9
|
13
|
|
| Total Current Assets |
27
|
45
|
289
|
348
|
375
|
562
|
|
| PP&E Net |
0
|
1
|
0
|
1
|
1
|
5
|
|
| PP&E Gross |
0
|
1
|
0
|
1
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
16
|
|
| Long-Term Investments |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Assets |
27
N/A
|
46
+67%
|
290
+534%
|
349
+20%
|
376
+8%
|
583
+55%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
2
|
0
|
3
|
3
|
|
| Accrued Liabilities |
1
|
2
|
7
|
16
|
26
|
56
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
0
|
0
|
0
|
1
|
14
|
|
| Total Current Liabilities |
2
|
2
|
9
|
17
|
30
|
73
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
6
|
6
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
7
|
|
| Total Liabilities |
8
N/A
|
8
+5%
|
9
+10%
|
17
+95%
|
30
+74%
|
80
+171%
|
|
| Equity | |||||||
| Common Stock |
33
|
95
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
13
|
57
|
128
|
270
|
459
|
554
|
|
| Additional Paid In Capital |
0
|
0
|
409
|
602
|
805
|
1 057
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
20
N/A
|
38
+91%
|
281
+644%
|
332
+18%
|
347
+4%
|
503
+45%
|
|
| Total Liabilities & Equity |
27
N/A
|
46
+67%
|
290
+534%
|
349
+20%
|
376
+8%
|
583
+55%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
60
|
60
|
62
|
74
|
87
|
101
|
|
Switch to:
Switch to:
See Also
Discover More
